Detalhe da pesquisa
1.
Combined Tumor-Based BRCA1/2 and TP53 Mutation Testing in Ovarian Cancer.
Int J Mol Sci
; 24(14)2023 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37511329
2.
HRness in Breast and Ovarian Cancers.
Int J Mol Sci
; 21(11)2020 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32481735
3.
BRCA1 and BRCA2 5' noncoding region variants identified in breast cancer patients alter promoter activity and protein binding.
Hum Mutat
; 39(12): 2025-2039, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30204945
4.
Case Report of Small Cell Carcinoma of the Ovary, Hypercalcemic Type (Ovarian Rhabdoid Tumor) with SMARCB1 Mutation: A Literature Review of a Rare and Aggressive Condition.
Curr Oncol
; 29(2): 411-422, 2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35200537
5.
Value of the loss of heterozygosity to BRCA1 variant classification.
NPJ Breast Cancer
; 8(1): 9, 2022 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35039532
6.
Genetic Landscape of Male Breast Cancer.
Cancers (Basel)
; 13(14)2021 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34298749
7.
Non-Coding Variants in BRCA1 and BRCA2 Genes: Potential Impact on Breast and Ovarian Cancer Predisposition.
Cancers (Basel)
; 10(11)2018 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30453575